New Key Statistics Module, Z-Score and F-Score
SZSE:002412 Key Ratios
Market Cap ¥ M | 2,626.70 |
Enterprise Value ¥ M | 2,391.71 |
P/E(ttm) | 12.22 |
PE Ratio without NRI | 12.00 |
Forward PE Ratio | -- |
Price/Book | 1.26 |
Price/Sales | 2.71 |
Price/Free Cash Flow | 23.20 |
Price/Owner Earnings | 19.41 |
Payout Ratio % | -- |
Revenue (TTM) ¥ M | 964.00 |
EPS (TTM) ¥ | 0.43 |
Beneish M-Score | -2.19 |
10-y EBITDA Growth Rate % | 6.20 |
5-y EBITDA Growth Rate % | 3.90 |
y-y EBITDA Growth Rate % | 24.60 |
EV-to-EBIT | 9.97 |
EV-to-EBITDA | 9.97 |
PEG | 3.08 |
Shares Outstanding M | 503.20 |
Net Margin (%) | 22.28 |
Operating Margin % | 23.24 |
Pre-tax Margin (%) | 25.07 |
Quick Ratio | 2.25 |
Current Ratio | 2.87 |
ROA % (ttm) | 9.16 |
ROE % (ttm) | 10.99 |
ROIC % (ttm) | 10.87 |
Dividend Yield % | -- |
Altman Z-Score | 6.05 |
SZSE:002412 Number of Guru Trades
SZSE:002412 Volume of Guru Trades
Gurus Latest Trades with SZSE:002412
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
SZSE:002412 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Hunan Hansen Pharmaceutical Co Ltd Insider Transactions
No Available Data